Skip to main content

Text Size

  • Increase
  • Decrease

Current Size: 100%

iSBTc Primer on Tumor Immunology and Biological Therapy of Cancer

This program provides a general overview of immunology as it applies to cancer etiology, biology and therapy. Topics of general interest such as Adoptive T Cell Therapy, Cancer Vaccines, Cytokines, Dendritic Cells, Immune Monitoring, Adaptive Immunity and Tumor Microenvironment will be presented.

The target audience for this program is basic and clinical investigators from academic, regulatory, and biopharmaceutical venues. The audience includes clinicians, researchers, students, post-doctoral fellows, and allied health professionals.

Fri, 01/10/2010
Address of event: 
Hyatt Regency Washington on Capitol Hill 400 New Jersey Ave NW Washington, D.C. 20001
USA
D.C.
Washington
20001
Event language: 
English
Host of event: 
International Society for Biological Therapy of Cancer (iSBTc)
UICC Member: 
No
Organiser: 
International Soiciety for Biological Therapy of Cancer
Organiser's contact adress: 
iSBTc 555 E. Wells Street, Suite 1100 Milwaukee, WI 53202 Tel: 414-271-2456 Fx: 414-276-3349 Email: info@isbtc.org
Contact name: 
Roseann Morotz
Email: 
info@isbtc.org
Phone: 
414-271-2456
Topics: 
Biotechnology
Breast
Brain
Cancer research
Cellular oncology
Clinical oncology
Colorectal
Education
Genomics
Haematology
Head and Neck
Leukaemia
Lung
Melanoma
Molecular biology
Oncology
Prostate
Skin Cancer
Surgery
Treatment / Therapy
Other topic: 
Vaccines, Immunotherapy
Under the auspices of UICC: 
Yes